🔴 Nasus Pharma is trading 6% down on October 12, 2026

Nasus Pharma is trading 5.98% down at $3.30, with no clear company-specific catalyst identified for October 12, 2026.

• The latest located company announcement concerned a Phase 1 study and was published September 29, not October 12.
• Supplied index moves are mixed and modest, so they do not establish a broad-market explanation for the decline.
• The provided price context shows a continued decline from the October 9 close of $3.51; October 12 volume data was not provided.